The valuation of a life science company includes the analysis and valuation of all components:
- Development projects in the pipeline today
- Future development projects based on the feed rate
- Burn rate
- Tax & tax credits
Interviews with the corporate management and with our specialist network ensure that the valuation is based on sound input parameters and not on gut feeling.
The discount rate for the valuation is elaborated for each company individually based on a genuine model that takes into account the development stage of the pipeline projects, the indications, the risk, the costs, and the strategy.
The valuation is performed using rNPV (DCF with success rates) and benchmarking approaches. The real options method can be performed under the request.